共 27 条
- [21] Differential expression of transforming growth factor-beta, basic fibroblast growth factor and their receptors in CD34 hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasiaBLOOD, 1995, 86 (10) : 176 - 176LeBousseKerdiles, MCCharpentier, AChevillard, SRomquin, NClay, DSmadjaJoffe, FPraloran, VDupriez, BDemory, JLJasmin, CMartyre, MC
- [22] Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34(+) hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasiaBLOOD, 1996, 88 (12) : 4534 - 4546LeBousseKerdiles, MCChevillard, SCharpentier, ARomquin, NClay, DSmadjaJoffe, FPraloran, VDupriez, BDemory, JLJasmin, CMartyre, MC
- [23] A Gene Expression Signature of CD34+Cells to Predict Major Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib: Potential Involvement of Beta-Catenin in Drug ResistanceBLOOD, 2009, 114 (22) : 210 - 210McWeeney, ShannonYochum, GregoryPemberton, Lucy C.Loriaux, MarcVartanian, KristinaWillis, Stephanie G.Wilmot, BethTurpaz, YaronPillai, RajiMac Partlin, MarySnead, JenniferDruker, Brian J.O'Brien, Stephen G.Melo, Junia V.Lange, ThoralfHarrington, ChristinaDeininger, Michael
- [24] Total number of CD34+cells per ten high power fields in bone marrow trephines of patients with chronic myeloid leukaemia correlates with probability of complete cytogenetic response during the first year of treatment with imatinib.BLOOD, 2004, 104 (11) : 250B - 250BElliot, VJMarin, DHorncastle, DElderfield, KHoward, JApperly, JFLampert, ANaresh, KN
- [25] Myeloablative conditioning of patients with myelofibrosis with myeloid metaplasia using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation (PBPCT) with high doses of CD34+cells results in hematologic responses - 32 months follow-up of three patients and short-term results of a new study.BLOOD, 2005, 106 (11) : 467B - 467BFruehauf, SBuss, ECToplay, JKreipe, HHHo, AD
- [26] Myeloablative conditioning of patients with myelofibrosis with myeloid metaplasia using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation (PBPCT) with high doses of CD34+cells results in hematologic responses - 32 months follow-up of three patients and short-term results of a new study.CYTOTHERAPY, 2006, 8Fruehauf, S.Buss, E. C.Topaly, J.Kreipe, H. H.Ho, A. D.
- [27] Monitoring By Chromosome Banding Analysis (CBA) and FISH Of Circulating CD34+Cells In Low-Risk MDS Patients Treated In The Le-Mon-5 Study With Lenalidomide Monotherapy Reveals 82% Cytogenetic Responders With Different Response -, Evolutionary -, and Remission Patterns and No Increased Karyotype Evolution (KE)BLOOD, 2013, 122 (21)Shirneshan, KatayoonPlatzbecker, UweNolte, FlorianGiagounidis, AristotelesGoetze, KatharinaSchlenk, Richard F.Luebbert, MichaelBug, GesineBraulke, FriederikeSchanz, JulieGerming, UlrichHaase, Detlef